All In MedTech

Device Trial Radar · NCT06429748

Symptom Evaluation Following Repetitive Transcranial Magnetic Stimulation

A Prospective Study to Evaluate Symptoms Following Repetitive Transcranial Magnetic Stimulation (rTMS)

Last checked: Nov 20, 2026Latest source record: Jun 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

20

Actual

Start

May 15, 2024

Primary completion

Apr 29, 2025

Study completion Dec 30, 2027

Sponsor

Lead sponsor
NeuroneticsAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
May 28, 2024

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 22 years, up to 70 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A prospective study to evaluate symptoms following repetitive transcranial Magnetic stimulation.

Conditions

  • Neurologic Symptoms

Interventions

  • rTMSDevice

    repetitive Transcranial Magnetic Stimultion

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Changes in multiple symptoms after rTMS treatment.Time frame: 4 weeks

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Charlotte Skin and Laser

    Charlotte, North Carolina

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.